FICS

Clinical trials and research traditionally existed outside of the care administered within local hospitals and physicians’ offices. Physicians weren’t always aware of what research was being conducted, and patients had little idea research that could potentially improve their outcome or benefit their health was occurring at all. Only Elligo enables broader participation in clinical research than ever before with access to over 150 million patients and their data, allowing physicians to provide research as a care option to patients who otherwise wouldn’t have access to clinical research. Traditional recruitment methods are constrained by limitations such as patient proximity to a specific site where research is conducted. Research has also shown that patients prefer to engage in a study with their trusted healthcare physician.

Deep 6 AI disrupts the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months. Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials. Deep 6 AI finds more patients for clinical trials in minutes rather than months, getting life-saving cures to people more quickly. Deep 6 AI’s software analyzes structured data, such as ICD-10 codes, and unstructured clinical data, including doctor’s notes, pathology reports, operating notes and other important medical data in free-text form that cannot be searched easily.